← REGULATORY CHANGES
FEDERAL REGISTER · RULEJanuary 27, 2025IN FORCE

Nonprescription Drug Product With an Additional Condition for Nonprescription Use

What this record is not

Document details are published in the U.S. Federal Register; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA or the Office of the Federal Register. The authoritative text is on federalregister.gov.

STATUSIN FORCE
EFFECTIVEMar 21, 2025
COMMENTS CLOSE—
APPLIES TO · SPEQ TAGDrug
Document type
Rule
Agency
Health and Human Services Department
Published
January 27, 2025
Effective
March 21, 2025
Document number
2025-01840
CFR references
21 CFR 201, 21 CFR 314
Docket
FDA-2021-N-0862
RIN
0910-AH62
ABSTRACT

In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) is delayed until March 21, 2025.

Abstract as published in the Federal Register.

SAME DOCKET · FDA-2021-N-0862

AMENDING THE SAME CFR PART · 21 CFR 201, 21 CFR 314

21 CFR 201 in the tracker's recent documents →

READ THE FULL DOCUMENT

The complete document — every provision, the docket, and the comment instructions — is published in the Federal Register. SPEQ surfaces and indexes it for reference; the authoritative text lives on federalregister.gov.

View on federalregister.gov →

That is what FDA published. A free account files it on your watchlist and sends one weekly email with whatever lands next.

Create a free account

PUT THIS CHANGE TO WORK

This week from FDAEvery Federal Register document from the last 7 days →Open comment windows57 open now, closing soonest first →GxP HorizonWhat comes into force next →